These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19589224)

  • 1. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research.
    Ye M; Fu S; Pi R; He F
    J Pharm Pharmacol; 2009 Jul; 61(7):831-7. PubMed ID: 19589224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders.
    Kulkarni SK; Dhir A
    Phytother Res; 2010 Mar; 24(3):317-24. PubMed ID: 19998323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations.
    Tang J; Feng Y; Tsao S; Wang N; Curtain R; Wang Y
    J Ethnopharmacol; 2009 Oct; 126(1):5-17. PubMed ID: 19686830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine: Pathways to protect neurons.
    Lin X; Zhang N
    Phytother Res; 2018 Aug; 32(8):1501-1510. PubMed ID: 29732634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
    Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
    BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    Ismail H; Khalid D; Waseem D; Ijaz MU; Dilshad E; Haq IU; Bhatti MZ; Anwaar S; Ahmed M; Saleem S
    PLoS One; 2023; 18(11):e0286349. PubMed ID: 37910530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the study of berberine and its derivatives].
    Li B; Zhu WL; Chen KX
    Yao Xue Xue Bao; 2008 Aug; 43(8):773-87. PubMed ID: 18956768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating Neuroprotective Potential of Berberine, Levetiracetam and their Combination in the Management of Alzheimer's Disease Utilizing Drug Repurposing Strategy.
    Singh A; Dhaneshwar S; Mazumder A
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):182-190. PubMed ID: 34515019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of berberine on mood disorders.
    Fan J; Zhang K; Jin Y; Li B; Gao S; Zhu J; Cui R
    J Cell Mol Med; 2019 Jan; 23(1):21-28. PubMed ID: 30450823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications.
    Xiao D; Liu Z; Zhang S; Zhou M; He F; Zou M; Peng J; Xie X; Liu Y; Peng D
    Mini Rev Med Chem; 2018; 18(17):1424-1441. PubMed ID: 28325147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption of extractive Rhizoma Coptidis in rat everted gut scas].
    Dong Y; Zhang YF; Yang Q; Li YJ; Bao TD; Weng XG; Pan GF; Zhu XX
    Zhongguo Zhong Yao Za Zhi; 2008 May; 33(9):1056-60. PubMed ID: 18652357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More than a decade of estrogen neuroprotection.
    Simpkins JW; Singh M
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S131-6. PubMed ID: 18631989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine.
    Imanshahidi M; Hosseinzadeh H
    Phytother Res; 2008 Aug; 22(8):999-1012. PubMed ID: 18618524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines.
    Maleki SN; Aboutaleb N; Souri F
    J Chem Neuroanat; 2018 Jan; 87():54-59. PubMed ID: 28495517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in structural modifications and biological activities of berberine: an active compound in traditional Chinese medicine.
    Huang ZJ; Zeng Y; Lan P; Sun PH; Chen WM
    Mini Rev Med Chem; 2011 Nov; 11(13):1122-9. PubMed ID: 22353221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine: Is it a Promising Agent for Mental Disorders Treatment?
    Shayganfard M
    Curr Mol Pharmacol; 2023; 16(3):307-320. PubMed ID: 35538795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural product berberine is a human prolyl oligopeptidase inhibitor.
    Tarrago T; Kichik N; Seguí J; Giralt E
    ChemMedChem; 2007 Mar; 2(3):354-9. PubMed ID: 17295371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine: a potential phytochemical with multispectrum therapeutic activities.
    Vuddanda PR; Chakraborty S; Singh S
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1297-307. PubMed ID: 20836620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia.
    Chai YS; Yuan ZY; Lei F; Wang YG; Hu J; Du F; Lu X; Jiang JF; Xing DM; Du LJ
    PLoS One; 2014; 9(6):e90850. PubMed ID: 24603897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.